Quest Diagnostics Reveals New Genetic Discoveries at ASH
Quest Diagnostics will present new discoveries during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans.
Read MoreMonth: December 2009
Medicare Reimbursement Coding Policy Established for MammaPrint Test
Agendia announces that Palmetto GBA, California’s Part B Medicare administrator, has established coding guidelines for the company’s MammaPrint test. MammaPrint is Agendia’s FDA-cleared breast cancer recurrence test.
Read MoreACMG Supports the SACGHS Gene Patenting Recommendations
The American College of Medical Genetics (ACMG) has a long-standing position that genes are products of nature, and as such should not be patentable.
Read MoreFDA Approves Roche Test to Screen Source Plasma Test for HIV, Hep B, Hep C
Roche announced today that the FDA approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations.
Read More
Product Showcase
Abbott Diagnostics Immunoassay System: ARCHITECT ci4100 The Abbott ARCHITECT® ci4100 integrated immunochemistry system, from Abbott, Abbott Park, Ill, is intended for low- to mid-volume laboratories providing productivity enhancements nor
Read More